Literature DB >> 21958887

Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease.

Alan S Go1, Nisha Bansal, Malini Chandra, Phenius V Lathon, Stephen P Fortmann, Carlos Iribarren, Chi-Yuan Hsu, Mark A Hlatky.   

Abstract

OBJECTIVES: The aim of this study was to examine whether kidney dysfunction is associated with the type of clinical presentation of coronary heart disease (CHD).
BACKGROUND: Reduced kidney function increases the risk for developing CHD, but it is not known whether it also influences the acuity of clinical presentation, which has important prognostic implications.
METHODS: A case-control study was conducted of subjects whose first clinical presentation of CHD was either acute myocardial infarction or stable exertional angina between October 2001 and December 2003. Estimated glomerular filtration rate (eGFR) before the incident event was calculated using calibrated serum creatinine and the abbreviated MDRD (Modification of Diet in Renal Disease) equation. Patient characteristics and use of medications were ascertained from self-report and health plan databases. Multivariable logistic regression was used to examine the association of reduced eGFR and CHD presentation.
RESULTS: A total of 803 adults with incident acute myocardial infarctions and 419 adults with incident stable exertional angina who had baseline eGFRs ≤130 ml/min/1.73 m(2) were studied. Mean eGFR was lower in subjects with acute myocardial infarctions compared with those with stable angina. Compared with eGFR of 90 to 130 ml/min/1.73 m(2), a strong, graded, independent association was found between reduced eGFR and presenting with acute myocardial infarction, with adjusted odds ratios of 1.36 (95% confidence interval: 0.99 to 1.86) for eGFR 60 to 89 ml/min/1.73 m(2), 1.55 (95% confidence interval: 0.92 to 2.62) for eGFR 45 to 59 ml/min/1.73 m(2), and 3.82 (95% confidence interval: 1.55 to 9.46) for eGFR <45 ml/min/1.73 m(2) (p < 0.001 for trend).
CONCLUSIONS: An eGFR <45 ml/min/1.73 m(2) is a strong, independent predictor of presenting with acute myocardial infarction versus stable angina as the initial manifestation of CHD.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21958887      PMCID: PMC3184235          DOI: 10.1016/j.jacc.2011.07.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

1.  Evaluating hypertension control in a managed care setting.

Authors:  M Alexander; I Tekawa; E Hunkeler; B Fireman; R Rowell; J V Selby; B M Massie; W Cooper
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

2.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Authors:  Santhi K Ganesh; Austin G Stack; Nathan W Levin; Tempie Hulbert-Shearon; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

Review 3.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Authors:  G A Block; F K Port
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

4.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

5.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

6.  Hematocrit level and associated mortality in hemodialysis patients.

Authors:  J Z Ma; J Ebben; H Xia; A J Collins
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

7.  C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.

Authors:  J Y Yeun; R A Levine; V Mantadilok; G A Kaysen
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

Review 8.  Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis).

Authors:  G A Block
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-11       Impact factor: 2.894

9.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

10.  Statin and beta-blocker therapy and the initial presentation of coronary heart disease.

Authors:  Alan S Go; Carlos Iribarren; Malini Chandra; Phenius V Lathon; Stephen P Fortmann; Thomas Quertermous; Mark A Hlatky
Journal:  Ann Intern Med       Date:  2006-02-21       Impact factor: 25.391

View more
  20 in total

1.  [Partial nephrectomy. Rationale and limitations of an organ-preserving approach].

Authors:  J Casuscelli; C Gratzke; C G Stief; M Staehler
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Patterns of care for renal surgery: Underutilization of nephron-sparing procedures.

Authors:  Jessica Hammett; Joan Ko; Nora Byrd; Paul L Crispen; Tracey L Krupski
Journal:  Can Urol Assoc J       Date:  2013-06-12       Impact factor: 1.862

Review 3.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

Review 4.  Treatment rationale for coronary heart disease in advanced CKD.

Authors:  K Lopau; C Wanner
Journal:  Herz       Date:  2021-02-10       Impact factor: 1.443

5.  In-hospital mortality in patients with renal dysfunction admitted for myocardial infarction: the Emilia-Romagna region of Italy database of hospital admissions.

Authors:  Fabio Fabbian; Marco Pala; Alfredo De Giorgi; Fabio Manfredini; Alessandra Mallozzi Menegatti; Raffaella Salmi; Francesco Portaluppi; Massimo Gallerani; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2012-07-25       Impact factor: 2.370

6.  Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney Disease.

Authors:  Benjamin Lidgard; Leila R Zelnick; Kevin D O'Brien; Nisha Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-17       Impact factor: 8.237

7.  Invasive Management for Non-ST-Segment-Elevation Myocardial Infarction and Chronic Kidney Disease: Does One Size Fit All?

Authors:  Ayman Elbadawi; Islam Y Elgendy; Paul Kumfa
Journal:  J Am Heart Assoc       Date:  2022-06-17       Impact factor: 6.106

8.  Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I.

Authors:  Ian Gunsolus; Yader Sandoval; Stephen W Smith; Anne Sexter; Karen Schulz; Charles A Herzog; Fred S Apple
Journal:  J Am Soc Nephrol       Date:  2017-10-27       Impact factor: 10.121

9.  Myocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient.

Authors:  Mozow Y Zuidema; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2012-03-30       Impact factor: 2.041

10.  Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease.

Authors:  Abdelhakim Allali; Hussein Traboulsi; Dmitriy S Sulimov; Mohamed Abdel-Wahab; Felix Woitek; Norman Mangner; Rayyan Hemetsberger; Nader Mankerious; Karim Elbasha; Ralph Toelg; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2021-07-13       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.